U.S. Transportation Stock News

Ardelyx recently cut its full-year 2026 IBSRELA revenue guidance to US$350–US$370 million, withdrew a long-term XPHOZAH sales target, filed a US$36 million shelf registration for an ESOP-related common stock offering, and announced the past resignation of Chief Commercial Officer Eric Foster effective August 28, 2026. Together, the lowered guidance, withdrawal of a key revenue goal, and leadership change underscore how payer hurdles are pressuring Ardelyx’s commercial execution and long-term...

With the Buffett Indicator hovering around 238% and Warren Buffett himself content to sit on a growing pile of cash and T bills, many investors are wondering whether more of their portfolio should also lean toward short duration assets. Elevated valuations and the war in Iran have sharpened interest in cash style exposure. This article unpacks that story and walks through 3 stocks exposed to this theme. The stocks covered below are just a starting sample of this short duration cash theme, and...

With the U.S. slapping 50% tariffs on selected Canadian imports and Canada firing back with dollar for dollar measures, cross border supply chains are under fresh pressure. That kind of shock can hurt some stocks and create room for others that are tied more closely to U.S. manufacturing and onshoring. This article walks through 3 stocks exposed to this news and how the shifting trade backdrop could matter for their stories. The stocks covered below are just a starting sample. The full screen...

Roblox stock has had a tough run over the past year, yet current valuation checks still suggest the shares are not a clear bargain even after that pullback. Roblox has declined 67.4% over the past year, which raises the question of whether recent weakness has been fully reflected in the current share price. Expectations for user and revenue growth can support the case for paying up for Roblox, while the ongoing investigation into alleged misrepresentations by certain officers and directors...

BILL Holdings (BILL) is back on investor radar after fiscal fourth quarter and full year results topped consensus forecasts, coupled with new 2027 guidance that points to slower core revenue growth but higher profitability and Rule of 40 ambitions. See our latest analysis for BILL Holdings. The latest earnings beat and 2027 guidance arrive after a sharp rebound in BILL Holdings’ share price, with a 30 day share price return of 14.16% and a 90 day share price return of 32.32%. That recent...

Virtus Investment Partners (VRTS) is back in focus after converting two Zevenbergen mutual funds into actively managed ETFs and announcing a higher quarterly dividend, developments that may influence how you think about the stock today. See our latest analysis for Virtus Investment Partners. Over the past year, Virtus Investment Partners has seen its share price show shorter term momentum, with a 90 day share price return of 16.34%, even as the 1 year total shareholder return declined 11.31%...

Lamb Weston Holdings stock has enjoyed a strong rebound this year, yet its recent history and valuation checks suggest investors may still be paying up for the shares. After a three year period where the stock declined 40.1%, the current pricing raises questions about how much of a recovery is already reflected in the market value. Over the past 3 years, Lamb Weston Holdings has delivered a 40.1% decline, which points to a challenging stretch for long term holders even with the more recent...

With Treasury yields hovering near multi year highs and rate cuts looking less certain, investors are weighing what higher borrowing costs and a stronger dollar could mean for long term portfolios. This is creating an opening for those who care about steady income and valuation discipline but also feel the recent pullback in equities might be overdone in places. This article walks through three dividend payers from our high quality screener that appear well aligned with the latest macro...

Vertex Pharmaceuticals (VRTX) lifted its full year 2026 revenue guidance after citing continued demand in cystic fibrosis treatments and broader uptake in sickle cell disease, beta thalassemia, and acute pain therapies. See our latest analysis for Vertex Pharmaceuticals. The guidance upgrade comes after a strong run in Vertex Pharmaceuticals stock, with a 30 day share price return of 15.97% and a 90 day share price return of 26.13%. The 1 year total shareholder return of 38.70% and 5 year...

Best Buy recently reported quarterly results for the period ended July 2026, with Wall Street having anticipated higher year-over-year earnings supported by increased revenues and the possibility of an earnings beat based on a positive Earnings ESP. This setup highlighted how even small differences between the Most Accurate Estimate and the broader consensus can meaningfully shift expectations around Best Buy’s near-term earnings momentum. Next, we’ll examine how the anticipated earnings...

Rare Element Resources (OTCPK:REEM.F) moved into focus after the company addressed online market research materials suggesting a possible new investment and an announcement as early as August 26, 2026. See our latest analysis for Rare Element Resources. The sharp 1 day share price decline of 28.45% and 7 day share price fall of 7.97% came after Rare Element Resources clarified that online speculation about a potential investment was unfounded. However, the 30 day share price return of 176.13%...

PHINIA (PHIN) shares are trading against a backdrop of leadership and segment changes after the company appointed Pedro Abreu as President of Power Systems and Daniel Griffin as President of Aftermarket Solutions. See our latest analysis for PHINIA. At a share price of US$72.75, PHINIA has had a 1 day share price return of 1.56%, while the 30 day share price return is down 8.77% and the 1 year total shareholder return is 26.52%. This suggests that longer term momentum has held up even as the...

HCA Healthcare recently reported a solid Q2 2026 performance with strong revenue and patient-volume growth, even as it trimmed its full-year outlook to reflect payer and service-mix pressures. Alongside plans to present at several upcoming healthcare conferences and continued investment in emergency care capacity, HCA is signaling an emphasis on operational efficiency and technology as it balances growth with reimbursement headwinds. Next, we will examine how HCA’s strong quarterly results...

Kimbell Royalty Partners (NYSE:KRP) closed a US$221.2 million acquisition, expanding its mineral and royalty interests in key US oil and gas basins. The transaction increases Kimbell's asset base and exposure to production cash flows tied to these properties. The deal represents a material development for investors focused on US energy royalty and mineral exposure. For readers interested in more ways to play resource linked cash flows, the next useful step is to review 28 best rare earth...

Texas Instruments (TXN) is drawing fresh attention after one valuation model lifted its fair value estimate from US$298.00 to US$324.45, giving investors an updated reference point for evaluating potential upside and downside. See our latest analysis for Texas Instruments. Despite recent strength in Q2 results and a higher fair value estimate, Texas Instruments’ share price has eased. The 30 day share price return is down 10.14% and the 90 day share price return is down 14.50%, while the 1...

A sustained rise in oil prices linked to supply concerns at the Strait of Hormuz and conflict in the Middle East has pushed ExxonMobil Holdings (XOM) into focus for investors watching cash flow and earnings resilience. See our latest analysis for ExxonMobil Holdings. ExxonMobil Holdings shares have pulled back slightly with a 1-day share price return of 0.63% decline to US$165.11, although the 30-day share price return of 6.90% and year to date share price return of 34.62% suggest momentum...

In recent commentary, BofA Securities highlighted that Ciena continues to face supply constraints, making backlog conversion and delivery performance a central concern ahead of its Q3 results investors have already been watching closely. This focus on how effectively Ciena can turn strong demand into actual shipments and revenue under ongoing supply challenges has become a key issue for assessing its operational execution. We’ll now examine how Ciena’s unresolved supply constraints, and...

With US–Canada trade talks breaking down and fresh 50% US tariffs hitting a wide range of Canadian goods, the story for North American manufacturing is changing fast. Cross border supply chains face more friction, which may push more production and investment onshore. For investors, that shift could benefit those who identify potential opportunities at an early stage. This article examines three stocks exposed to this news and explains why they may deserve a closer look now. The three stocks...

Norwegian Cruise Line Holdings has seen its share price decline about 34.1% over the past five years, yet current market multiples screen the stock as undervalued and the broader valuation checks send a more cautious, mixed message. After a period of weaker recent returns, investors are weighing whether the current price fairly reflects both the company’s challenges and its efforts to refresh the fleet and guest offering. Over five years the stock is down about 34.1%, which suggests long...

Recent commentary on Rush Enterprises (RUSH.A) highlights declining sales, falling earnings per share, and weakening returns on capital. Together, these factors suggest sustained pressure on its core truck related markets and profitability profile. See our latest analysis for Rush Enterprises. Despite the operational headwinds, Rush Enterprises’ share price has shown strong momentum over longer periods. The 30 day share price return is 3.18% and the year to date share price return is 45.65%,...

Transocean stock has almost doubled over the past year, yet the valuation signals are split. The Discounted Cash Flow (DCF) intrinsic value estimate points to about 12.4% upside, while market based multiples lean expensive and the broader checks do not flag the stock as a clear bargain. Transocean has returned 94.7% over the past year, which puts extra focus on whether that share price move is ahead of the company’s fundamentals. The new US$300 million, two year drillship contract with ONGC...

Ameresco (NYSE:AMRC) is supporting the extension of the Sweetheart Lake Hydroelectric Project, highlighting its engineering and project management role in the build out of new energy infrastructure. The company outlined its involvement as the project moves toward execution readiness, adding a large hydro asset to its portfolio of clean energy work. Ameresco announced executive changes, including the resignation of its Chief Financial Officer and a long-serving General Counsel and board...

In the past week, Waste Connections reported second-quarter 2026 results that exceeded earnings and revenue estimates, raised its 2026 revenue outlook to about US$10.02–US$10.05 billion, and projected adjusted EBITDA of roughly US$3.33–US$3.34 billion alongside expected margin expansion. The company also disclosed that it completed acquisitions representing around US$100 million in annualized revenue in the first half of 2026 and anticipates an above-average year for further deals,...

Earlier this week, Zacks upgraded Mettler-Toledo International to a Rank #2 (Buy), citing an upward trend in earnings estimates and improving business fundamentals. This shift in analyst sentiment comes despite earlier concerns about softer organic growth and rising competition, highlighting renewed confidence in the company’s profit outlook. Next, we’ll examine how this earnings-estimate upgrade might influence Mettler-Toledo’s existing investment narrative around margins, growth, and...